Valuation
26% of the score
0median 13
An operating loss over the last year: there are no earnings to price.
GILDGilead Sciences
$152.21+36% 1Y
$152.21
$108.5052 weeks$153.91
RyuScore
Seven criteria, each scored 0 to 100 on a published scale, weighted into one number.
RyuScore 44 out of 100, Below average
Below average. Gilead Sciences scores higher than 40% of the 1,794 companies Ryufin scores.
Carried by cycle position and return on capital, held back by valuation and return on new capital.
Healthcare median 27 · all companies 50
Return on capital
18% of the score
65median 34
Over 7 years the business earned 12% a year after tax on the capital it uses.
2%
8%
15%
25%
12%
None at 2% or less, full points from 25%full points
7 years agolatest 21%
Return on new capital
16% of the score
27median 49
For every dollar of operating profit earned over 6 years, yearly profit grew by 0 cents. It did so while using less capital than before.
-5%
12%
-0.4%
None at minus 5 cents, full points from 12 centsfull points
Capital allocation
14% of the score
79median 64
How management spends the money: shares bought back or issued, and whether assets grow faster than the business they serve.
Share countDown 0.1% a year over 5 years: buybacks
645%
-3%
-0.1%
0 pointsfull points
Assets against salesAssets grew -2.9% a year, sales 3.6%
10012%
-2%
-6.5%
0 pointsfull points
Cycle position
12% of the score
100median 62
Today's operating margin of -8.2% is -0.28x its normal 29%: near a trough. Normal is half the 10 year median, half the last four years, so a margin that has held is not taken for a peak.
2x
1.5x
1x
0.7x
-0.3x
A trough earns points, a peak costs themfull points
10 years agonow -8.2%
Balance sheet
8% of the score
0median 50
What the debt weighs against the profit that has to carry it.
Net debt to EBITDANet debt with no operating cash profit.
0Interest coverOperating profit covers interest -3x
01.5x
12x
-2.5x
0 pointsfull points
Earnings quality
6% of the score
82median 90
Whether the reported profit arrives as cash, and whether the accounts show the usual signs of stretching.
Cash against profitOperating cash flow was 1.97x profit over 3 years
1000.7x
1x
1.3x
2x
0 pointsfull points
AccrualsCash ran ahead of profit by 2.6% of assets
738%
0%
-8%
-2.6%
0 pointsfull points
Beneish M-score-2.45
72-1.50
-1.78
-2.22
-3.00
-2.45
0 pointsfull points
How the RyuScore works
Each criterion earns 0 to 100 points on the scale drawn under it, and the RyuScore is their average weighted 26, 18, 16, 14, 12, 8 and 6. Scales bend in the company's favour between their ends, so an ordinary figure is never already near zero. Where a criterion cannot be measured from the filings it is taken out and the remaining weights scale up; a company needs 60% of the weight covered, and always a price, to get a score.
Built from the company's annual and quarterly filings with the SEC and today's share price. Banks, insurers and property trusts are not scored: their debt is their raw material, so these yardsticks mean something else there. Figures as of 2026-06-30, latest annual report FY2025.
On our screens:Cheap stocks by free cash flow yield
Drug Manufacturers, General
The closest names by size in the same industry